<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm Tags: drug samples</title>
        <description>MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'drug samples'.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=%22drug+samples%22&t=%22drug+samples%22&r=Exact&o=d&f=tag]]></link>
        <lastBuildDate>Sat, 03 Sep 2011 02:41:21 +0100</lastBuildDate>
        <item>
            <title>How Many Doctors Won’t Accept Samples?</title>
            <link>http://www.medworm.com/index.php?rid=5097080&amp;cid=t_205487_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2Fbeac5L8CjbE%2F</link>
            <description>And the number is&amp;#8230; 23 percent. That&amp;#8217;s right - 23 percent of physicians will not accept free samples from drugmakers, according to a new survey of 168,834 medical offices representing approximately 480,000 physicians in 56 therapeutic specialties that was conducted by Cegedim&amp;#8217;s SK&amp;#038;A unit. This is a rather large figure, although optimists will say that 77 percent of physicians are still taking samples.
Of course, this varies by specialty. For instance, 96 percent of allergists and immunologists are happy to take samples, as are 92 percent of urologists, dermatologists and opthalmologists. By contrast, 67 percent of sports medicine practitioners and 62 percent sleep medicine specialists accept samples. Eight of the 56 specialties surveyed had acceptance rates of 90 perc...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5097080</comments>
            <pubDate>Fri, 05 Aug 2011 13:47:54 +0100</pubDate>
            <guid isPermaLink="false">5097080</guid>        </item>
        <item>
            <title>Pharming For Business? More Docs Have An iPad</title>
            <link>http://www.medworm.com/index.php?rid=4789636&amp;cid=t_205487_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FUtb6qNBvltg%2F</link>
            <description>One year after its launch, the iPad is proving hot with docs. A new survey finds that 30 percent of US physicians now own the Apple tablet and another 28 percent plan to purchase an iPad within the next six months, according to a survey of 2,041 doctors by Manhattan Research.
In fact, 75 percent of all docs in the US own some type of Apple device, such as an iPhone, iPad or iPod (see the statement). The finding is potentially significant, at least when one considers that docs can access electronic medical records on their iPad. The implications for EMR providers is rather obvious, since iPad accessibility may be a deciding factor for some practices when selecting an EMR provider.
There can be implications for drugmakers, too. Pharma can use the EMR app on iPad to interact with docs by prov...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4789636</comments>
            <pubDate>Thu, 05 May 2011 12:16:36 +0100</pubDate>
            <guid isPermaLink="false">4789636</guid>        </item>
        <item>
            <title>Medical Residencies Closing The Door On Pharma?</title>
            <link>http://www.medworm.com/index.php?rid=4636659&amp;cid=t_205487_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2F5PvEgH1s4QA%2F</link>
            <description>The pharmaceutical industry has traditionally established ties to doctors during their formative years in residency programs, but more recently, drugmakers have been shunned by several high-profile academic medical centers over concerns of undue influence on medical practice. Now, a new study in Academic Medicine finds that a wide array of family medicine residencies are taking similar steps. 
The researchers conducted a nationwide survey of family medicine residencies to determine the extent and type of industry interactions with trainees and to identify so-called pharma-free residencies that avoided iindustry influence. And so they e-mailed four questions to residency directors or coordinators at all 460 accredited US family med residencies. In all, 286 replied.
The findings: 75 residenc...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4636659</comments>
            <pubDate>Fri, 25 Mar 2011 14:11:57 +0100</pubDate>
            <guid isPermaLink="false">4636659</guid>        </item>
        <item>
            <title>Free Drug Samples Or Hospital Hotels: The Greater Evil?</title>
            <link>http://www.medworm.com/index.php?rid=4532210&amp;cid=t_205487_87_f&amp;fid=39187&amp;url=http%3A%2F%2Fgetbetterhealth.com%2Ffree-drug-samples-or-hospital-hotels-the-greater-evil%2F2011.02.28</link>
            <description>Many folks criticize pharmaceutical companies for providing physicians’ offices with free drug samples. They claim that this giveaway harms consumers because drug companies must raise their prices to cover the costs of these freebies. Of course, this is undeniable. Any business expense, such as payroll or advertising, has to be covered and is expectedly borne by the consumer. If a company chooses not to advertise, outsources manufacturing to a country with cheaper labor, offers limited benefits to its employees, then they can sell their product at a low price. In this hypothetical example, anemic sales may doom the company quickly.
Naturally, free samples are not really free. The rest of us pay for them. While this is true, I don’t think it is evil. Unlike the U.S. government, at least...</description>
            <author>Better Health</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4532210</comments>
            <pubDate>Mon, 28 Feb 2011 20:00:00 +0100</pubDate>
            <guid isPermaLink="false">4532210</guid>        </item>
        <item>
            <title>Doctor To Rep: ‘I Do Not Have Time To Talk To You’</title>
            <link>http://www.medworm.com/index.php?rid=4419449&amp;cid=t_205487_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FsKSooOatmvM%2F</link>
            <description>What do reps really think of docs who keep them waiting? Who won&amp;#8217;t give them a few seconds to hear about a new indication or sign a sample form? How about the receptionist? And why is she swiveling her hips?
Hat tip to Pharmagossip (Source: Pharmalot)</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4419449</comments>
            <pubDate>Mon, 31 Jan 2011 16:25:00 +0100</pubDate>
            <guid isPermaLink="false">4419449</guid>        </item>
        <item>
            <title>Pharmalot… Pharmalittle… Good Morning</title>
            <link>http://www.medworm.com/index.php?rid=4281552&amp;cid=t_205487_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FXw5i4ajxIVo%2F</link>
            <description>Hello, everyone, and top of the morning to you. Another shiny day is unfolding here on the Pharmalot corporate campus, where we are scrambling to do too many things at once. Sounds familiar, yes? To cope, we are quaffing yet another cup of stimulation. Meanwhile, here are some tidbits to help you along. Hope your day is productive and do stay in touch&amp;#8230;
Arena To Refile Obesity Drug By End Of 2011 (Reuters)
Biogen And Elan Want To Update Tysabri Label (Bloomberg News)
J&amp;#038;J Shareholders File Suit Over Manufacturing Gaffes (Bloomberg News)
Novo Sales Rep Sues For Wrongful Termination (West Virginia Record)
Teva And Takeda Settle Actos Patent Lawsuit (Reuters)
Vertex Ends Part Of Telaprevir Study For Hepatitis C (Bloomberg News)
Pharmacist Jailed For Mail Fraud (Standard Speaker) (Sou...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4281552</comments>
            <pubDate>Wed, 22 Dec 2010 13:17:56 +0100</pubDate>
            <guid isPermaLink="false">4281552</guid>        </item>
        <item>
            <title>Pfizer's Sales Reps Have 48 Hours to Out Deliver eSampling Program. #FAIL!</title>
            <link>http://www.medworm.com/index.php?rid=4266259&amp;cid=t_205487_150_f&amp;fid=34889&amp;url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2010%2F12%2Fpfizers-sales-reps-have-48-hours-to-out.html</link>
            <description>Discussion Board:&quot;Why spend $300 for a sample drop when FedEx will do it for $20. Forcing reps on physicians to drop sample - the old pharma model continues&quot;&quot;This is a joke, reps have 48 hrs to deliver the goods ? Why not overnight them for $10 and not pay the rep $400.00 / day income. Gas and insurance in the car etc. Folks this gig has a very very short horizon ahead, think for yourselves.&quot;Other anonymous CafePharma &quot;reps,&quot; however, think it is a good idea:&quot;Reps are right, the sample calls are a huge part of getting in to see the Drs. The other side is, no sample calls, no calls.&quot;&quot;it's much more convincing when you have a rep &quot;close&quot; a doctor and won't take no for answer that you know you're going to have to callback for more freebie samples to subsidize those patients complaining about ...</description>
            <author>Pharma Marketing Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4266259</comments>
            <pubDate>Wed, 15 Dec 2010 14:06:00 +0100</pubDate>
            <guid isPermaLink="false">4266259</guid>        </item>
        <item>
            <title>Docs Still Like Sales Reps To Deliver Samples</title>
            <link>http://www.medworm.com/index.php?rid=3798823&amp;cid=t_205487_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FvZzvbOT6mlo%2F</link>
            <description>Even as drugmakers continue to throw sales reps overboard, a new survey finds that most doctors continue to prefer to have reps deliver their samples. The findings suggest that, despite the rush to encourage docs to order samples online either directly or through a third-party supplier, sample delivery offers an opportunity to engage docs.
The survey found that 73 percent of physicians still like to have reps deliver samples compared with just 20 percent who prefer online E-sampling services. And 75 percent of primary care physicians obtained their samples directly from reps compared with 15 percent going online. There was no data, though, on sample requests. the The survey, which was conducted by DTW Marketing, canvassed 100 docs between May 7 and June 3, 2010.
However, as another recent ...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3798823</comments>
            <pubDate>Wed, 28 Jul 2010 13:26:40 +0100</pubDate>
            <guid isPermaLink="false">3798823</guid>        </item>
        <item>
            <title>End All Pharma Freebies to Physicians by Decree or Just Leave it at Caveat Doctor?</title>
            <link>http://www.medworm.com/index.php?rid=2406172&amp;cid=t_205487_150_f&amp;fid=34889&amp;url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2009%2F05%2Fend-all-pharma-freebies-to-physicians.html</link>
            <description>Has the time come for physicians to be forcibly weaned away from ALL pharma &quot;freebies,&quot; including CME and drug samples? Or should the principle caveat doctor be emphasized?An editorial in today's issue of Archives of Internal Medicine (Arch Intern Med. 2009;169[9]:829-831), a medical journal published by the American Medical Association, entitled &quot;Time for the Medical Profession to Act,&quot; argues that it is time to prohibit pharma companies from providing free gifts, free meals, free CME, and free samples to physicians.The author, Philip Greenland, MD, of the Feinberg School of Medicine (Northwesetrn University) points out that the new PhRMA Code on Interactions with Healthcare Professionals (see PMN Reprint #77-01) does not prohibit sponsorship of office-based or hospital-based meals, conti...</description>
            <author>Pharma Marketing Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2406172</comments>
            <pubDate>Mon, 11 May 2009 21:00:00 +0100</pubDate>
            <guid isPermaLink="false">2406172</guid>        </item>
        <item>
            <title>Another rule or two to circumvent</title>
            <link>http://www.medworm.com/index.php?rid=2132560&amp;cid=t_205487_97_f&amp;fid=35606&amp;url=http%3A%2F%2Fwww.theangriestpharmacist.com%2F2009%2F01%2F25%2Fanother-rule-or-two-to-circumvent%2F</link>
            <description>I&amp;#8217;m excited. We&amp;#8217;ve got more rules to break or circumvent. Are you?
http://tinyurl.com/NoMorePens &amp;#8212; News Article
http://tinyurl.com/BigPharma &amp;#8212; Members of PhRMA

As you all may have heard, certain pharmaceutical companies have recently adopted a new &amp;#8220;ETHICS POLICY&amp;#8221; banning all gift-giving to prescribers. They are still allowed, however, to disperse &amp;#8220;EDUCATIONAL MATERIAL&amp;#8221; as well as meals for &amp;#8220;office-based lessons.&amp;#8221; [I read this as &quot;LOTION&quot; for &quot;HANDJOBS&quot; or &quot;BREASTS&quot; for &quot;GAWKING' AT&quot; -- with the lotion being slapped with a FORTAMET sticker, of course!]
We all know that this is horseshit (what Pharma said &amp;#8212; what I said is right on the money). While they cannot give away pens, clocks, stress balls, calendars, scissors, stapler...</description>
            <author>The Angriest Pharmacist</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2132560</comments>
            <pubDate>Sun, 25 Jan 2009 17:00:29 +0100</pubDate>
            <guid isPermaLink="false">2132560</guid>        </item>
        <item>
            <title>Pfizer Relpax Rep Rejected, Then Welcomed When He Offered Free Samples for Doc's Personal Use</title>
            <link>http://www.medworm.com/index.php?rid=1943361&amp;cid=t_205487_150_f&amp;fid=34889&amp;url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2008%2F11%2Fpfizer-relpax-rep-rejected-then.html</link>
            <description>Free drug samples that pharmaceutical sales reps give to physicians are supposed to help patients who cannot afford the prescription and/or to test if the product works on a particular patient.Of course, we all know that free samples are the drug rep's last great hope of gaining access to physicians after the distribution of freebies -- pens, calendars, clocks, etc. -- comes into disfavor on January 1, 2009.It's not clear whether or not free drug samples help uninsured patients afford their medication (see &quot;Drug Samples: To those that have, it shall be given. The rest pay list price!&quot;), but what IS clear is that many physicians and their office personnel divert free drug samples for their own use. Such diversion is unethical and may even be illegal.How do I know this happens? For one thing...</description>
            <author>Pharma Marketing Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1943361</comments>
            <pubDate>Fri, 07 Nov 2008 15:40:00 +0100</pubDate>
            <guid isPermaLink="false">1943361</guid>        </item>
        <item>
            <title>Drug samples - just say NO!</title>
            <link>http://www.medworm.com/index.php?rid=1856022&amp;cid=t_205487_150_f&amp;fid=34768&amp;url=http%3A%2F%2Fpharmagossip.blogspot.com%2F2008%2F10%2Fdrug-samples-just-say-no.html</link>
            <description>A new study suggests that free drug samples, an effective marketing tool for the drug industry, do little to help the poor and may put children’s health at risk.Researchers from Harvard medical school analyzed data from a federal survey, and found that in 2004 children in the lowest income group weren’t more likely than those in the highest group to get free samples — in part because poor children have less access to doctors overall. And uninsured children were more likely than those with insurance to get the samples.Free samples are often given for new drugs that have less of a proven safety record than older medicines, one of the study’s authors told the New York Times. And samples sometimes lack specific instructions for children.More (Source: PharmaGossip)</description>
            <author>PharmaGossip</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1856022</comments>
            <pubDate>Tue, 07 Oct 2008 11:00:00 +0100</pubDate>
            <guid isPermaLink="false">1856022</guid>        </item>
    </channel>
</rss>

